[1] |
林家达, 温必盛, 陈绵富, 等. 肠黏膜相关菌群与老年溃疡性结肠炎患者疾病活动程度的相关性[J]. 中华保健医学杂志,2021,23(5):523-524.
|
[2] |
龚建萍, 李倩, 赵述芳, 等. 免疫因素在溃疡性结肠炎发病机制中的研究进展[J]. 现代消化及介入诊疗,2020,25(12):1676-1679.
|
[3] |
Alhmoud T, Gremida A, Colom Steele D, et al. Outcomes of inflammatory bowel disease in patients with eosinophil-predominant colonic inflammation[J]. BMJ Open Gastroenterol,2020,7(1):e000373.
|
[4] |
Magro F, Lopes J, Borralho P, et al. Comparison of the Nancy index with continuous Geboes score: histological remission and response in ulcerative colitis[J]. J Crohns Colitis,2020,14(7):1021-1025.
|
[5] |
Chateau T, Feakins R, Marchal-Bressenot A, et al. Histological remission in ulcerative colitis: under the microscope is the cure[J].Am J Gastroenterol,2020,115(2):179-189.
|
[6] |
屈霄, 王靓, 陆萍, 等. 外周血炎症因子及肠道菌群特征与活动性溃疡性结肠炎患者病情的相关性分析[J/CD]. 中华消化病与影像杂志(电子版),2023,13(6):466-470.
|
[7] |
Deng L, He XY, Tang B, et al. An improved quantitative realtime polymerase chain reaction technology for Helicobacter pylori detection in stomach tissue and its application value in clinical precision testing[J]. BMC Biotechnol,2020,20(1):33.
|
[8] |
Shirzad-Aski H, Besharat S, Kienesberger S, et al. Association between Helicobacter pylori colonization and inflammatory bowel disease: a systematic review and meta analysis[J]. J Clin Gastroenterol,2021,55(5):380-392.
|
[9] |
Ali I, Abdo Q, Al-Hihi SM, et al. Association between ulcerative colitis and Helicobacter pylori infection: A case-control study[J].Heliyon,2022,8(2):e08930.
|
[10] |
Fujita Y, Tominaga K, Tanaka T, et al. Ulcerative colitis relapse after Helicobacter pylori eradication in a 12-year-old boy with duodenal ulcer[J]. BMC Gastroenterol,2021,21(1):424.
|
[11] |
Kahlam A, Khrais A, Khalessi A, et al. Trends and complication rates in ulcerative colitis patients with and without Helicobacter pylori infections[J]. Cureus,2023,15(4):e37345.
|
[12] |
Liu W, Jiang Q, Xue S, et al. Clinical characteristics of ulcerative colitis patients with different types of Helicobacter pylori infection[J].Microbiol Spectr,2024,12(5):e0355423.
|
[13] |
中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见[J]. 中华内科杂志,2012,51(10):818-831.
|
[14] |
Satsangi J. The Montreal classification of inflammatory bowel disease:controversies, consensus, and implications[J]. Gut,2006,55(6):749-753.
|
[15] |
Bewtra M, Brensinger CM, Tomov VT, et al. An optimized patientreported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index[J]. Inflamm Bowel Dis,2014,20(6):1070-1078.
|
[16] |
Rubin DT, Huo D, Kinnucan JA, et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a casecontrol study[J]. Clin Gastroenterol Hepatol,2013,11(12):1601-1608.
|
[17] |
徐宝琪, 张燕红, 李伊倩. 溃疡性结肠炎患者不同发病状态肠道菌群, 炎症因子变化及优势菌敏感性抗菌药物分析[J/CD]. 中华实验和临床感染病杂志(电子版),2020,14(1):51-56.
|
[18] |
段婷娜, 刘芳. 美沙拉秦灌肠液联合双歧杆菌三联活菌肠溶胶囊治疗溃疡性结肠炎的临床效果及对患者炎症因子水平的影响[J]. 中国医药,2021,16(4):579-582.
|
[19] |
Nakase H, Sato N, Mizuno N, et al. The influence of cytokines on the complex pathology of ulcerative colitis[J]. Autoimmun Rev,2022,21(3):103017.
|
[20] |
龚秀敏, 詹玮, 尹明. 溃疡性结肠炎患者肠道菌群分布, 炎性因子水平及发病相关因素分析[J]. 临床消化病杂志,2020,32(5):290-294.
|
[21] |
Bai X, Jiang L, Ruan G, et al. Helicobacter pylori may participate in the development of inflammatory bowel disease by modulating the intestinal microbiota[J]. Chin Med J (Engl),2022,135(6):634-638.
|
[22] |
沈华娟, 庄剑波, 刘春. 幽门螺杆菌感染抗体分型与胃黏膜炎性病变程度及黏膜组织学变化间的相关性[J/CD]. 中华实验和临床感染病杂志(电子版),2024,18(3):156-162
|
[23] |
曾会, 唐玉虎, 陈志娟. 幽门螺杆菌感染血清学抗体与胃镜下胃溃疡患者病理特点的相关性分析[J]. 贵州医药,2020,44(2):299-301.
|
[24] |
方莉萍, 冯胜春, 朱亦璇, 等. 金华地区幽门螺旋杆菌感染情况及抗体分型分析[J]. 中国卫生检验杂志,2022,2(23):2870-2872.
|
[25] |
Kishk RM, Soliman NM, Anani MM, et al. Genotyping of Helicobacter pylori virulence genes cagA and vacA: regional and national study[J]. Int J Microbiol,2021,2021:5540560.
|